Cargando…

Regulatory B Cells in Systemic Sclerosis Isolated or Concomitant With Hashimoto Thyroiditis

Systemic sclerosis (SSc) is a systemic autoimmune disease in which gastrointestinal disorders represent a complication in up to 90% of patients. SSc may associate with thyroid autoimmune disorders, with Hashimoto’s thyroiditis (HT) being the more prevalent worldwide. Previous studies have examined t...

Descripción completa

Detalles Bibliográficos
Autores principales: Capriello, Silvia, Ferrari, Silvia Martina, Gatto, Ilenia, Santaguida, Maria Giulia, Fallahi, Poupak, Antonelli, Alessandro, Mangino, Giorgio, Romeo, Giovanna, Virili, Camilla, Centanni, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296862/
https://www.ncbi.nlm.nih.gov/pubmed/35874691
http://dx.doi.org/10.3389/fimmu.2022.921260
_version_ 1784750353381588992
author Capriello, Silvia
Ferrari, Silvia Martina
Gatto, Ilenia
Santaguida, Maria Giulia
Fallahi, Poupak
Antonelli, Alessandro
Mangino, Giorgio
Romeo, Giovanna
Virili, Camilla
Centanni, Marco
author_facet Capriello, Silvia
Ferrari, Silvia Martina
Gatto, Ilenia
Santaguida, Maria Giulia
Fallahi, Poupak
Antonelli, Alessandro
Mangino, Giorgio
Romeo, Giovanna
Virili, Camilla
Centanni, Marco
author_sort Capriello, Silvia
collection PubMed
description Systemic sclerosis (SSc) is a systemic autoimmune disease in which gastrointestinal disorders represent a complication in up to 90% of patients. SSc may associate with thyroid autoimmune disorders, with Hashimoto’s thyroiditis (HT) being the more prevalent worldwide. Previous studies have examined the behavior of Th17 lymphocytes and Breg cells in patients with HT and concomitant autoimmune organ-specific disorders. These immune phenotypes seem to play a significant role in the pathogenesis of both these autoimmune processes, but their behavior when these two disorders coexist has not been described. We analyzed Th17 and Breg (CD24hiCD38hi) cell subsets in 50 subjects (45F/5M; median age = 49 years): 18 were healthy donors (HD), 20 had isolated HT, and 12 had SSc, seven of whom had both HT and SSc. Breg cells’ function was also evaluated by measuring their IL-10 production when stimulated by specific activators. An increased percentage of Th17 lymphocytes characterized HT patients as compared to both HD and the whole group of SSc patients (p = 0.0018). On the contrary, the percentage of unstimulated Breg cells in SSc patients was higher (p = 0.0260), either associated or not with HT, as compared to both HT patients and HD, which, instead, showed a similar percentage of Breg cells. Following a specific stimulation with CpG, the percentages of Breg cells were increased in the whole sample of SSc patients (p < 0.001) as well as in isolated SSc and in SSc+HT ones as compared to isolated HT. However, qualitative analysis, obtained through the detection of the IL-10-producing phenotype, revealed that the percentage of CpG-stimulated CD24hiCD38hi-IL10+cells was significantly decreased in SSc patients (p < 0.0001) with no difference between isolated SSc and SSc+HT patients. The IL-10-producing phenotype was instead slightly increased in HT patients as compared to HD (4.1% vs. 2.8%). The presence of SSc seems to be characterized by an enrichment of total Breg cells but by a reduced Breg IL-10-producing phenotype, representing functional Bregs. This last finding was entirely due to the presence of SSc independently from the association with HT. This behavior is different from the ones described about the association of HT with organ-specific autoimmune disorders.
format Online
Article
Text
id pubmed-9296862
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92968622022-07-21 Regulatory B Cells in Systemic Sclerosis Isolated or Concomitant With Hashimoto Thyroiditis Capriello, Silvia Ferrari, Silvia Martina Gatto, Ilenia Santaguida, Maria Giulia Fallahi, Poupak Antonelli, Alessandro Mangino, Giorgio Romeo, Giovanna Virili, Camilla Centanni, Marco Front Immunol Immunology Systemic sclerosis (SSc) is a systemic autoimmune disease in which gastrointestinal disorders represent a complication in up to 90% of patients. SSc may associate with thyroid autoimmune disorders, with Hashimoto’s thyroiditis (HT) being the more prevalent worldwide. Previous studies have examined the behavior of Th17 lymphocytes and Breg cells in patients with HT and concomitant autoimmune organ-specific disorders. These immune phenotypes seem to play a significant role in the pathogenesis of both these autoimmune processes, but their behavior when these two disorders coexist has not been described. We analyzed Th17 and Breg (CD24hiCD38hi) cell subsets in 50 subjects (45F/5M; median age = 49 years): 18 were healthy donors (HD), 20 had isolated HT, and 12 had SSc, seven of whom had both HT and SSc. Breg cells’ function was also evaluated by measuring their IL-10 production when stimulated by specific activators. An increased percentage of Th17 lymphocytes characterized HT patients as compared to both HD and the whole group of SSc patients (p = 0.0018). On the contrary, the percentage of unstimulated Breg cells in SSc patients was higher (p = 0.0260), either associated or not with HT, as compared to both HT patients and HD, which, instead, showed a similar percentage of Breg cells. Following a specific stimulation with CpG, the percentages of Breg cells were increased in the whole sample of SSc patients (p < 0.001) as well as in isolated SSc and in SSc+HT ones as compared to isolated HT. However, qualitative analysis, obtained through the detection of the IL-10-producing phenotype, revealed that the percentage of CpG-stimulated CD24hiCD38hi-IL10+cells was significantly decreased in SSc patients (p < 0.0001) with no difference between isolated SSc and SSc+HT patients. The IL-10-producing phenotype was instead slightly increased in HT patients as compared to HD (4.1% vs. 2.8%). The presence of SSc seems to be characterized by an enrichment of total Breg cells but by a reduced Breg IL-10-producing phenotype, representing functional Bregs. This last finding was entirely due to the presence of SSc independently from the association with HT. This behavior is different from the ones described about the association of HT with organ-specific autoimmune disorders. Frontiers Media S.A. 2022-07-06 /pmc/articles/PMC9296862/ /pubmed/35874691 http://dx.doi.org/10.3389/fimmu.2022.921260 Text en Copyright © 2022 Capriello, Ferrari, Gatto, Santaguida, Fallahi, Antonelli, Mangino, Romeo, Virili and Centanni https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Capriello, Silvia
Ferrari, Silvia Martina
Gatto, Ilenia
Santaguida, Maria Giulia
Fallahi, Poupak
Antonelli, Alessandro
Mangino, Giorgio
Romeo, Giovanna
Virili, Camilla
Centanni, Marco
Regulatory B Cells in Systemic Sclerosis Isolated or Concomitant With Hashimoto Thyroiditis
title Regulatory B Cells in Systemic Sclerosis Isolated or Concomitant With Hashimoto Thyroiditis
title_full Regulatory B Cells in Systemic Sclerosis Isolated or Concomitant With Hashimoto Thyroiditis
title_fullStr Regulatory B Cells in Systemic Sclerosis Isolated or Concomitant With Hashimoto Thyroiditis
title_full_unstemmed Regulatory B Cells in Systemic Sclerosis Isolated or Concomitant With Hashimoto Thyroiditis
title_short Regulatory B Cells in Systemic Sclerosis Isolated or Concomitant With Hashimoto Thyroiditis
title_sort regulatory b cells in systemic sclerosis isolated or concomitant with hashimoto thyroiditis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296862/
https://www.ncbi.nlm.nih.gov/pubmed/35874691
http://dx.doi.org/10.3389/fimmu.2022.921260
work_keys_str_mv AT capriellosilvia regulatorybcellsinsystemicsclerosisisolatedorconcomitantwithhashimotothyroiditis
AT ferrarisilviamartina regulatorybcellsinsystemicsclerosisisolatedorconcomitantwithhashimotothyroiditis
AT gattoilenia regulatorybcellsinsystemicsclerosisisolatedorconcomitantwithhashimotothyroiditis
AT santaguidamariagiulia regulatorybcellsinsystemicsclerosisisolatedorconcomitantwithhashimotothyroiditis
AT fallahipoupak regulatorybcellsinsystemicsclerosisisolatedorconcomitantwithhashimotothyroiditis
AT antonellialessandro regulatorybcellsinsystemicsclerosisisolatedorconcomitantwithhashimotothyroiditis
AT manginogiorgio regulatorybcellsinsystemicsclerosisisolatedorconcomitantwithhashimotothyroiditis
AT romeogiovanna regulatorybcellsinsystemicsclerosisisolatedorconcomitantwithhashimotothyroiditis
AT virilicamilla regulatorybcellsinsystemicsclerosisisolatedorconcomitantwithhashimotothyroiditis
AT centannimarco regulatorybcellsinsystemicsclerosisisolatedorconcomitantwithhashimotothyroiditis